Neuroprotection, excitotoxicicity and NMDA antagonists

Arquivos de Neuro-Psiquiatria

Volumn 58, Issue 2 B, 2000, Pages 583-588

  Gagliardi, Rubens José ^a  

^a NONE   (Brazil)

Author keywords

Excitotoxicity; Neuroprotection; NMDA antagonists; Stroke

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; AMPA RECEPTOR ANTAGONIST; CALCIUM; GLUTAMIC ACID; GROWTH FACTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; POTASSIUM CHANNEL STIMULATING AGENT; SCAVENGER; SODIUM CHANNEL BLOCKING AGENT; AMINO ACID RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPROTECTIVE AGENT; NEUROTOXIN;

ARTICLE; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; DRUG EFFECT; HYPOTHERMIA; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; PATHOPHYSIOLOGY; BRAIN; DRUG ANTAGONISM; HUMAN; METABOLISM; REVIEW;

BRAIN; BRAIN ISCHEMIA; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0033624367     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x2000000300030     Document Type: Article

References (25)

1. Choi DW. Methods for antagonizing glutamate neurotoxicity. Cerebrovasc Brain Metab Rev 1990;2:105-147
2. Greenamyre JT, Porter RHP. Anatomy and physiology of glutamate in the CNS. Neurology 1994;44(Suppl):S7-S13
3. Sette G, Toni D, De Michele M, et al. Pharmacotheraphy of stroke: an overview In Krieglstein J, Oberpichler-Schwenk H. Pharmacology of cerebral ischemia. Stuttgart Medpharm Scient Publ: 1994;605-610.
4. Jay TM-Neurotransmitter systems In Mraovitch S, Sercombe R. Neurophysiological basis of cerebral blood flow control: an introduction. London: John Libbley & Co: 1996:63-87.
5. Olney JW, Ho OL, Rhee V. Cytotoxic effects of acidic and sulphur containing amino acids on the infant mouse central nervous system. Exp Brain Res 1971,14:61-76
6. Bucham AM. Do NMDA antagonists protect against cerebral ischemia: are clinical trials warrented? Cerebrovasc Brain Metab Rev 1990;2:1-26.
7. Hillend L, Hallstrom A, Segersvard S, Person L, Understedt U. Dynamics of extracellular metabolic in the striatum after middle cerebral artery occlusion in the rat, in monitored by intracerebral microdialysis. J Cereb Blood Flow Metab 1989;9:607-616
8. Dávalos A, Castillo J, Serena J, Noya M. Duration of glutamate release after acute ischemic stroke. Stroke 1997,28:708-710.
9. Choi DW, Rothan SM. The glutamate neurotoxicity in hipoxic-ischemic neuronal death. Ann Rev Neurosc 1990;13:171-182.
10. Faraci F, Brian JE. Nitric oxide and the cerebral circulation. Stroke 1994;25:692-703.
11. Hossmann KA. Periinfarct Depolarizations. Cerebrosvasc brain Metab Rev 1996;8:195-208.
12. Grotta J. Lubeluzole treatment of acute ischemic stroke. Stroke 1997;28:2338-2346.
13. Sacchetti ML, Toni D, Fiorelli M, Argentino C, Fieschi C. The concept of combination therapy in acute ischemic stroke. Neurology 1997;49(Suppl):70-74.
14. Muir KW, Grosset DG. Neuroprotection for acute stroke making clinical trials work. Stroke 1999;30:180-182.
15. Grotta J. A Glimpse to the future: multitherapy trials. Cerebrovasc Dis 1995;5(Suppl):27-30.
16. Meldrum BS. The role of glutamate in epilepsy and other CNS Disorders. Neurology 1994;44(Suppl):14-23.
17. Calabresi P, Marfia GA, Centonze D, Pisani A, Bernardi G. Sodium influx plays a major role in the membrane depolarization induced by oxygen and glucose deprivation in rat striatal spiny neurons. Stroke 1999;30:171-179.
18. Gifford RG, Monyer H, Christine CW, Choi DW. Acidosis reduces NMDA receptor activation, glutamate neurotoxicity, and oxygen-glicose deprivation neuronal injury in cortical cultures. Brain Res 1990;506:339-342.
19. Choi DW. Editorial Comment. Stroke 1996; 27:2130
20. Flavin MP. Influence of dexamethasone on neurotoxicity caused by oxygen and glicose deprivation in vitro. J Neuropath Exp Neurol 1996;39:34-38.
21. Pringle AK, Benham CD, Sim L, Kennedy J, Iannotti F, Sundstrom LE. Selective N-type calcium channel antagonist omega conotoxin mviia is a neuroprotective against hypoxic neurodegeneration in organotypic hippocampal-slice cultures. Stroke 1996;27:2124-2130.
22. Krupinski J, Issa R, Bujny T, et al., A Putative role for platelet-derived growth factor in angiogenesis and neuroprotection after ischemic stroke in humans. Stroke 1997;28:564-573.
23. Coimbra C, Drake M, Boris-Möller F, Wieloch T. Long-lasting neuroprotective effect of postischemic hypothermia and treatment with anti-inflammatory / antipyretic drug. Stroke 1996;27:1578-1585.
24. Veltkamp R, Domoki F, Bari F, Busija DW. Potassium channel activators protect the m-methil d-aspartate-induced cerebral vascular dilatation after combined hypoxia and ischemia in piglets. Stroke 1998;29:837-843.
25. Wei EP, Kontos HA, Beckmen JS-Antioxidants inhibit ATP-sensitive potassium channels in cerebral arterioles. Stroke 1998;29:817-823